Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV)

Parkinsonism and Related Disorders

Volumn 10, Issue 7, 2004, Pages 433-437

  Serrano Dueñas, Marcos ^a,b,c   Martínez Martín, Pablo ^b   Vaca Baquero, Verónica ^c  

^a HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

^b CARLOS III INSTITUTE OF HEALTH   (Spain)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

Author keywords

Cross cultural validation; Health related quality of life; Parkinson's disease; PDQL; PDQL EV

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE DURATION; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL ASPECT; UNITED KINGDOM;

AGED; ANXIETY; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DEPRESSION; ECUADOR; EMOTIONS; FEMALE; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL BEHAVIOR;

EID: 4644282276     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2004.05.002     Document Type: Article

References (38)

1. Guyatt G.H., Feeny D.H., Patrick D.L. Measuring health-related quality of life. Ann Intern Med. 118:1993;622-629
2. Schipper H., Clinch J.J., Olweny C.L.M. Quality of life studies: definitions and conceptual issues. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.:1996;11-23 Lippincot-Raven Publishers, Philadelphia
3. Martínez-Martín P. An introduction to the concept of "quality of life in Parkinson's disease" J Neurol. 245:(Suppl 1):1998;2-5
4. Damiano A.M., Snyder C., Strausser B., Willian M.K. A review of health-related quality-of-life concepts and measures for Parkinson's disease. Qual Life Res. 8:1999;235-243
5. Schrag A., Jahansahi M., Quinn N.P. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry. 69:2000;308-312
6. Martínez Martín P. Health-related quality of life in Parkinson's disease: outcomes of the therapeutic interventions. Expert Rev Pharmacoecon Outcomes Res. 1:2001;99-108
7. Rubenstein L.M., DeLeo A., Chrischilles E.A. Economic and health-related quality of life considerations of new therapies in Parkinson's disease. Pharmacoeconomics. 19:2001;729-752
8. Patrick D.L., Erickson P. Health status and health policy. Quality of life in health care evaluation and resource allocation. 1993;Oxford University Press, New York. p. 113-42
9. Spilker B. Introduction. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.:1996;1-10 Lippincot-Raven Publishers, Philadelphia
10. Ware J. Standards for validating health measures: definition and content. J Chronic Dis. 40:1987;473-480
11. Fitzpatrick R., Alonso J. Quality of life in health care: concepts and components. Martínez-Martín P., Koller W.C. Quality of life in Parkinson's disease. 1999;1-15 Masson SA, Barcelona
12. Peto V., Jenkinson C., Fitzpatrick R., Greenhall R. The development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res. 4:1995;241-248
13. De Boer A.G.E.M., Wijker W., Speelman J.D., De Haes J.C.J.M. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry. 61:1996;70-74
14. Calne S., Schulzer M., Mak E. Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's impact scale (PIMS). Parkinsonism Relat Disord. 2:1996;55-61
15. Brod M., Mendelsohn G.A., Roberts B. Patients' experiences of Parkinson's disease. J Gerontol. 53B:1998;213-222
16. Van den Berg M. Leben mit parkinson: Entwicklung und psychometrische testung des fragenbogens PLQ. J Neurol Rehabil. 4:1998;221-226
17. Welsh M., McDermott M.P., Holloway R.G., Plumb S., Pfeiffer R., Hubble J., The Parkinson Study Group. Development and testing of the Parkinson's disease quality of life scale. Mov Disord. 18:2003;637-645
18. Acquadro C., Jambon B., Ellis D. Language and translation issues. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.:1996;575-585 Lippincot-Raven Publishers, Philadelphia
19. Anderson R.T., McFarlane M., Naughton M.J., Shumaker S.A. Conceptual issues and considerations in cross-cultural validation of generic health-related quality of life instruments. Spilker B. Quality of life and pharmacoeconomics in clinical trials. 2nd ed.:1996;605-612 Lippincot-Raven Publishers, Philadelphia
20. Gibb W.R.G., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 51:1988;745-752
21. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 23:1975;433-441
22. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology. 17:1967;427-442
23. Schwab R.S., England A.C. Gillingham E.J., Donaldson I.M.L. Projection technique for evaluating surgery in Parkinson's disease. Third Symposium on Parkinson's Disease. 1969;152-157 E and S Livingstone, Edinburgh
24. Fahn S., Elton R.L., Members of The UPDRS Development Committee. Fahn S., Marsden C.D., Goldstein M., Calne D.B. Unified Parkinson's disease rating scale. Recent development in Parkinson's disease. vol. 2:1987;153-163 McMillan, New Jersey
25. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 67:1983;361-370
26. Hobson P., Holden A., Meara J. Measuring the impact of Parkinson's disease with the Parkinson's disease quality of life questionnaire. Age Ageing. 28:1999;341-346
27. Sheikh J., Yesavage J. Geriatric depression scale (GDS): recent findings and development of a shorter version. Brink T. Clinical Gerontology: a guide to assessment and intervention. 1986;165 Howarth Press, New York
28. Webster D. Critical analysis of the disability in Parkinson's disease. Moder Treat. 5:1968;257-282
29. Marinus J., Ramaker C., Van Hilten J.J., Stiggelbout A.M. Health-related quality of life in Parkinson's disease: a systematic review of disease specific instruments. J Neurol Neurosurg Psychiatry. 72:2002;241-248
30. Bland J.M., Altman D.G. Cronbach's alpha. Br Med J. 314:1997;572
31. Wyrwich K.W., Tierney W.M., Wolinsky F.D. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 52:1999;861-873
32. Terwee C.B., Dekker F.W., Wiersinga W.M., Prummel M.F., Bossuyt P.M.M. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res. 12:2003;349-362
33. Chrischilles A., Rubenstein L., Voelker M., Wallace R., Rodnitzky R. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord. 8:2002;199-209
34. Martínez Martín P., Frades Payo B. The "Grupo Centro" for study of movement disorders. Quality of life in Parkinson's disease. Validation study of the PDQ-39 Spanish version. J Neurol. 245:(Suppl 1):1998;34-38
35. Karlsen K.H., Tandberg E., Arsland D., Larsen J.P. Health-related quality of life in Parkinson's disease: a prospective longitudinal study. J Neurol Neurosurg Psychiatry. 69:2000;584-589
36. Kuopio A.M., Marttila R.J., Helenius H., Toivonen M., Rinne U.K. The quality of life in Parkinson's disease. Mov Disord. 15:2000;216-223
37. Schrag A., Selai C., Jahanshahi M., Quinn N.P. The EQ-5D - a generic quality of life measure - is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 69:2000;67-73
38. Martínez-Martín P., Frades B., Jiménez Jiménez F.J., et al. The PDQ-39 Spanish version: reliability and correlation with the short-form health survey (SF-36). Neurología. 14:1999;159-163